BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

KV Pharmaceutical sales and marketing update

KV and its Ther-Rx Corp. subsidiary reduced the list price of Makena hydroxyprogesterone caproate by 54% to $690 per injection from $1,500. KV also said it will offer supplemental rebates that in addition to the standard Medicaid rebate of 23.1% will result in a reduced cost...

Read the full 218 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >